MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Long Term Provisions | ₹155 Cr | ₹123 Cr | ₹98 Cr | ₹80 Cr | ₹72 Cr |
What is the latest Long Term Provisions ratio of MANKIND PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2025 | ₹155 Cr |
Mar2024 | ₹123 Cr |
Mar2023 | ₹98 Cr |
Mar2022 | ₹80 Cr |
Mar2021 | ₹72 Cr |
How is Long Term Provisions of MANKIND PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2025 | ₹155 Cr | 25.94 | |
Mar2024 | ₹123 Cr | 25.78 | |
Mar2023 | ₹98 Cr | 22.36 | |
Mar2022 | ₹80 Cr | 10.74 | |
Mar2021 | ₹72 Cr | - |
Compare Long Term Provisions of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹107,171.1 Cr | 1.1% | -0.2% | 11% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 2.1% | 0.3% | -9.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | -0% | 1.1% | 13.4% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | -1.1% | -3.2% | -4.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 3.4% | 0.2% | 8.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | -0.7% | 2% | 0.7% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 1.1% |
-0.2% |
11% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses